Freestone Capital Holdings, LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1470876
Seattle, WA
Position in RYTM
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$321,789
-$74,259 QoQ
Shares Held
3,700
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Freestone Capital Holdings, LLC holds $6,301,304 across 14 Biotechnology names. RYTM ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
|
442,500 | $1,991,250 | |
| 2 | IMNM |
Immunome Inc.
|
61,514 | $1,345,311 | |
| 3 | BNTX |
BioNTech SE
|
7,914 | $703,396 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
900 | $401,886 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
464 | $358,504 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
3,700 | $321,789 | |
| 7 | EXEL |
Exelixis, Inc.
|
7,001 | $300,272 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
2,109 | $205,100 |
All Filings in RYTM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,789 | 3,700 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $396,048 | 3,700 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $373,663 | 3,700 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $233,803 | 3,700 | Shares | Defined | 2025-08-05 | |
| 2024-12-31 | $207,126 | 3,700 | Shares | Defined | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||